Our Technologies

Renovos offers a portfolio of products to meet the needs of the orthopaedic regenerative medicine industry, by supporting researchers with novel solutions, and by addressing the unmet clinical needs within the orthopaedic space.

Renovos is developing a proprietary nanoclay platform technology for safer and more efficient localised delivery of biologics and regenerative medicine applications.

Our commercial proposition also includes research-grade human bone marrow mesenchymal stem cells and a high-value screening services in a low-impact animal model for testing of novel materials and compounds for biocompatibility, toxicology, angiogenesis and regeneration (bone/cartilage).

lab technician with pipette